Neboglamine
Neboglamine (CR-2249; XY-2401) is a modulator for N-methyl-D-aspartate (NMDA) receptor. Neboglamine increases the levels of fos-like immunoreactivity (FLI) -positive cells in the prefrontal cortex, nucleus accumbens, and lateral septal nucleus in rat models, .restores NMDA (HY-17551) -mediated neurotransmitter release, and inhibits phencyclidine-induced hyperlocomotion[1].
Product Specifications
CAS Number
[163000-63-3]
Product Name Alternative
CR-2249; XY-2401
UNSPSC
12352211
Hazard Statement
H302
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/neboglamine.html
Smiles
OC(CC[C@H](N)C(NC1CCC(C)(CC1)C)=O)=O
Molecular Formula
C13H24N2O3
Molecular Weight
256.34
Precautions
P264-P270-P330-P501
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
MET (Hepatocyte Growth Factor Receptor, HGF Receptor, HGF/SF Receptor, Proto-oncogene c-Met, Scatter Factor Receptor, SF Receptor, Tyrosine-protein Kinase Met) (MaxLight 650) discontinued
Tns1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Bovine GTP:AMP phosphotransferase, mitochondrial, AK3 ELISA KIT
